Assessment of the Optimal Amount of Proteins at Breakfast for Children
Not Applicable
Completed
- Conditions
- Healthy Children
- Interventions
- Other: Protein-based beverage
- Registration Number
- NCT02465151
- Lead Sponsor
- Société des Produits Nestlé (SPN)
- Brief Summary
The primary objective of this trial is to identify how much protein is required at breakfast to promote positive whole body protein balance over the following 9h period.
- Detailed Description
This study will be the first to establish the role of eating protein at breakfast on whole body protein balance in healthy children.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
- Aged between 7-12 years of age
- Healthy and recreationally physically active (obtaining a 3- day average moderate/vigorous physical activity of at least 30 min/day)
- Body mass at ≥10th percentile for 7 year olds and ≤85th percentile for 12 year olds. Values based upon 2000 CDC Growth Charts for the United States
- Having obtained his/her informed assent
- Having obtained his/her consent from parent or legal guardian
- Being able to communicate in local language
- Have a habitual daily protein consumption of between 1.6 g/kg and 2.4 g/kg/bw
Exclusion Criteria
- Self-report on regular medication impacting the metabolism, such as corticoids, hormone (e.g thyroid, adrenal) treatment, or medication against diabetes or against hypercholesterolemia or hypertriglyceridemia
- Self-reported history of metabolic, hepatic or renal disease
- Self-reported allergy to milk proteins (e.g., whey or casein) or intolerance to any food ingredients to be used in the study products and meals
- Within 1.5 years of estimated age of peak height velocity (PHV)
- Special diet or weight loss program (e.g Atkins diet)
- Consuming breakfast containing more than 21g of protein on each day of the 3-d screening period
- Subject who cannot be expected to comply with the study procedures, including unwillingness to consume study product and meals
- Currently participating or having participated in another nutritional-clinical trial during the last 2 months prior to the beginning of this study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Low Protein Protein-based beverage - High Protein Protein-based beverage - No Protein Protein-based beverage - Medium Protein Protein-based beverage -
- Primary Outcome Measures
Name Time Method Whole body protein balance (g protein/9 hours) by nitrogen balance technique 9 hours following ingestion of investigational product
- Secondary Outcome Measures
Name Time Method Whole body protein balance (g protein/24 hours) by nitrogen balance technique 24 hours following ingestion of investigational product
Trial Locations
- Locations (1)
Goldring Centre for High Performance Sport at University of Toronto
🇨🇦Toronto, Ontario, Canada